Human butyrylcholinesterase components differ in aryl acylamidase activity

Biological Chemistry

Volumn 389, Issue 4, 2008, Pages 425-432

  Montenegro, María F ^a   Moral Naranjo, María T ^a   Páez De La Cadena, María ^b   Campoy, Francisco J ^a   Muñoz Delgado, Encarnación ^a   Vidal, Cecilio J ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b UNIVERSITY OF VIGO   (Spain)

Author keywords

Blood serum; Cholinesterases; Colon; Human; Kidney

Indexed keywords

ACETANILIDE DERIVATIVE; ACETYLCHOLINESTERASE; AMIDASE; BUTYRYLTHIOCHOLINE; CHOLINESTERASE; ESTERASE; GUANINE NUCLEOTIDE BINDING PROTEIN; MONOMER; OLIGOMER; TETRAMER;

ARTICLE; COLON; ENZYMATIC DEGRADATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME STRUCTURE; ENZYME SUBUNIT; HYDROLYSIS; KIDNEY; OLIGOMERIZATION; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN PROCESSING;

ACETANILIDES; AMIDOHYDROLASES; BUTYRYLCHOLINESTERASE; CHOLINESTERASES; COLON; HUMANS; KIDNEY; MOLECULAR STRUCTURE; SUBSTRATE SPECIFICITY;

TRIFLUORO;

EID: 44649154460     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2008.041     Document Type: Article

References (49)

1. Altamirano, C.V. and Lockridge, O. (1999). Conserved aromatic residues of the C-terminus of human butyrylcholinesterase mediate the association of tetramers. Biochemistry 38, 13414-13422.
2. Balasubramanian, A.S. and Bhanumathy, C.D. (1993). Noncholinergic functions of cholinesterases. FASEB J. 7, 1354-1358.
3. Boopathy, R. and Layer, P.G. (2004). Aryl acylamidase activity on acetylcholinesterase is high during early chicken brain development. Protein J. 23, 325-333.
4. Boopathy, R., Rajesh, R.V., Darvesh, S., and Layer, P.G. (2007). Human serum cholinesterase from liver pathological samples exhibit highly elevated aryl acylamidase activity. Clin. Chim. Acta 380, 151-156.
5. Chatonnet, F., Boudinot, E., Chatonnet, A., Taysse, L., Daulon, S., Champagnat, J., and Foutz, A.S. (2003). Respiratory survival mechanism in acetylcholinesterase knockout mouse. Eur. J. Neurosci. 18, 1419-1427.
6. Checler, F., Grassi, J., and Vincent, J.P. (1994). Cholinesterases display genuine arylacylamidase activity but are totally devoid of intrinsic peptidase activities. J. Neurochem. 62, 756-763.
7. Cokugras, A.N. (2003). Butyrylcholinesterase: structure and physiological importance. Turk. J. Biochem. 28, 54-61.
8. Darvesh, S., Hopkins, D.A., and Geula, C. (2003a). Neurobiology of butyrylcholinesterase. Nat. Neurosci. 4, 131-138.
9. Darvesh, S., Walsh, R., and Martin, E. (2003b). Enatiomer effects of huperzine A on the aryl acylamidase activity of human cholinesterases. Cell. Mol. Neurobiol. 23, 93-100.
10. Darvesh, S., McDonald, R.S., Darvesh, K.V., Mataija, D., Mothana, S., Cook, H., Carneiro, K.M., Richard, N., Walsh, R., and Martin, E. (2006). On the active site for the hydrolysis of aryl amides and choline esters by human cholinesterases. Bioorg. Med. Chem. 14, 4586-4599.
11. Diamant, S., Podoly, E., Friedler, A., Ligumsky, H., Livnah, O., and Soreq, H. (2006). Butyrylcholinesterase attenuates amyloid fibril formation in vitro. Proc. Natl. Acad. Sci. USA 103, 8628-8633.
12. Fujimoto, D. (1976). Serotonin-sensitive aryl acylamidase activity of acetylcholinesterase. FEBS Lett. 72, 121-123.
13. George, S.T. and Balasubramanian, A.S. (1981). The aryl acylamidase and their relationship to cholinesterase in human serum, erythrocyte and liver. Eur. J. Biochem. 121, 177-186.
14. Geula, C. and Mesulam, M.M. (1995). Cholinesterase and the pathology of Alzheimer disease. Alzheimer Dis. Assoc. Disord. 9, 23-28.
15. Giles, K. (1997). Interactions underlying subunit association in cholinesterases. Protein Eng. 10, 677-685.
16. Greig, N.H., Utsuki, T., Ingram, D.K., Wang, Y., Pepeu, G., Scali, C., Yu, Q.S., Mamczarz, J., Holloway, H.W., Giordano, T., et al. (2005). Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer b-amyloid peptide in rodent. Proc. Natl. Acad. Sci. USA 102, 17213-17218.
17. Jaganathan, L. and Boopathy, R. (2000). Distinct effect of benzalkonium chloride on the esterase and aryl acylamidase activities of butyrylcholinesterase. Bioorg. Chem. 28, 242-251.
18. Kálman, J., Juhász, A., Rakonczay, Z., Ábrahá m, G., Zana, M., Boda, K., Farkas, T., Penke, B., and Janka, Z. (2004). Increased serum butyrylcholinesterase activity in type IIb hyperlipidaemic patients. Life Sci. 75, 1195-1204.
19. Layer, P.G. and Willbold, E. (1995). Novel functions of cholinesterases in development, physiology and disease. Prog. Histochem. Cytochem. 29, 1-94.
20. Li, B., Stribley, J.A., Ticu, A., Xie, W., Schopfer, L.M., Hammond, P., Brimijoin, S., Hinrichs, S.H., and Lockridge, O. (2000). Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J. Neurochem. 75, 1320-1331.
21. Lockridge, O. (1990). Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine. Pharmacol. Ther. 47, 35-60.
22. Lockridge, O. and La Du, B.N. (1982). Loss of the interchain disulfide peptide and dissociation of the tetramer following limited proteolysis of native human serum cholinesterase. J. Biol. Chem. 257, 12012-12018.
23. Lockridge, O., Schopfer, L.M., Winger, G., and Woods, J.H. (2005). Large scale purification of butyrylcholinesterase from human plasma suitable for injection into monkeys; a potential new therapeutic for protection against cocaine and nerve agent toxicity. J. Med. CBR Def. 3, 1-20.
24. Loewenstein, Y., Gnatt, A., Neville, L.F., and Soreq, H. (1993). Chimeric human cholinesterase. Identification of interaction sites responsible for recognition of acetyl- or butyrylcholinesterase-specific ligands. J. Mol. Biol. 234, 289-296.
25. Mack, A. and Robitzki, A. (2000). The key role of butyrylcholinesterase during neurogenesis and neural disorders: an antisense- 5′butyrylcholinesterase-DNA study. Prog. Neurobiol. 60, 607-628.
26. Manoharan, I. and Boopathy, R. (2006). Diisopropylfluorophosphate- sensitive aryl acylamidase activity of fatty acid free human serum albumin. Arch. Biochem. Biophys. 452, 186-188.
27. Masson, P., Froment, M.T., Darvesh, S., Schopfer, L.M., and Lockridge, O. (2007a). Aryl acylamidase activity of human serum albumin with o-nitrotrifluoroacetanilide as the substrate. J. Enzyme Inhib. Med. Chem. 22, 463-469.
28. Masson, P., Froment, M.T., Gillon, E., Nachon, F., Darvesh, S., and Schopfer, L.M. (2007b). Kinetic analysis of butyrylcholinesterase-catalyzed hydrolysis of acetanilides. Biochim. Biophys. Acta 1774, 1139-1147.
29. Massoulié, J. (2002). The origin of the molecular diversity and functional anchoring of cholinesterases. Neurosignals 11, 130-143.
30. Massoulié, J., Bon, S., Perrier, N., and Falasca, C. (2005). The C-terminal peptides of acetylcholinesterase: cellular trafficking, oligomerization and functional anchoring. Chem. Biol. Interact. 157-158, 3-14.
31. Mattes, C.E., Lynch, T.J., Singh, A., Bradley, R.M., Kellaris, P.A., Brady, R.O., and Dretchen, K.L. (1997). Therapeutic use of butyrylcholinesterase for cocaine intoxication. Toxicol. Appl. Pharmacol. 145, 372-380.
32. Meshorer, E. and Soreq, H. (2006). Virtues and woes of AChE alternative splicing in stress-related neuropathologies. Trends Neurosci. 29, 216-224.
33. Montenegro, M.F., Ruiz-Espejo, F., Campoy, F.J., Muñoz-Delgado, E., Páez de la Cadena, M., Rodríguez-Berrocal, F.J., and Vidal, C.J. (2006). Cholinesterases are down-expressed in human colorectal carcinoma. Cell. Mol. Life Sci. 63, 2175-2182.
34. Moral-Naranjo, M.T., Campoy, F.J., Cabezas-Herrera, J., and Vidal, C.J. (1999). Increased butyrylcholinesterase levels in microsomal membranes of dystrophic Lama2dy mouse muscle. J. Neurochem. 73, 1138-1144.
35. Nicolet, Y., Lockridge, O., Masson, P., Fontecilla-Camps, J.C., and Nachon, F. (2003). Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products. J. Biol. Chem. 278, 41141-41147.
36. Oommen, A. and Balasubramanian, A.S. (1979). The association of the serotonin-sensitive aryl acylamidase with acetylcholinesterase in the monkey brain. Eur. J. Biochem. 94, 135-143.
37. Perrier, A.L., Massoulié, J., and Krejci, E. (2002). PRiMA: the membrane anchor of acetylcholinesterase in the brain. Neuron 33, 275-285.
38. Ruiz-Espejo, F., Cabezas-Herrera, J., Illana, J., Campoy, F.J., and Vidal, C.J. (2002). Cholinesterase activity and acetylcholinesterase glycosylation are altered in human breast cancer. Breast Cancer Res. Treat. 72, 11-22.
39. Ruiz-Espejo, F., Cabezas-Herrera, J., Illana, J., Campoy, F.J., Muñoz-Delgado, E., and Vidal, C.J. (2003). Breast cancer metastasis alters acetylcholinesterase activity and the composition of enzyme forms in axillary lymph nodes. Breast Cancer Res. Treat. 80, 105-114.
40. Russ, C., Powell, S., Lovestone, S., and Holmes, C. (1998). K variant of butyrylcholinesterase and late-onset Alzheimer's disease. Lancet 351, 881.
41. Sáez-Valero, J. and Vidal, C.J. (1996). Biochemical properties of acetyl- and butyrylcholinesterase in human meningioma. Biochim. Biophys. Acta 1317, 210-218.
42. Saxena, A., Redman, A.M., Jiang, J., Lockridge, O., and Doctor, B.P. (1997). Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase. Biochemistry 36, 14642-14651.
43. Shin, I., Wachtel, E., Roth, E., Bon, C., Silman, I., and Weiner, L. (2002). Thermal denaturation of Bungarus fasciatus acetylcholinesterase: is aggregation a driving force in protein unfolding? Protein Sci. 11, 2022-2032.
44. Sridhar, G.R., Thota, H., Allam, A.R., Babu, C.S., Prasad, A.S., and Divakar, Ch. (2006). Alzheimer's disease and type 2 diabetes mellitus: the cholinesterase connection? Lipids Health Dis. 5, 28-32.
45. Suarez, D. and Field, M.J. (2005). Molecular dynamics simulation of human butyrylcholinesterase. Proteins 59, 104-117.
46. Tornel, P.L., Sáez-Valero, J., and Vidal, C.J. (1992). Ricinus communis agglutinin I reacting and non-reacting butyrylcholinesterase in human cerebrospinal fluid. Neurosci. Lett. 145, 59-62.
47. Treskatis, S., Ebert, C., and Layer, P.G. (1992). Butyrylcholinesterase from chicken brain is smaller than that from serum: its purification, glycosylation and membrane association. J. Neurochem. 58, 2236-2247.
48. Weitnauer, E., Robitzki, A., and Layer, P.G. (1998). Aryl acylamidase activity exhibited by butyrylcholinesterase is higher in chick than in horse, but much lower than in fetal calf serum. Neurosci. Lett. 254, 153-156.
49. Yagüe-Guirao, A., Muñoz-Delgado, E., and Vidal, C.J. (1986). Thermal stability of molecular forms of acetylcholinesterase from muscle microsomes. Biochem. Int. 12, 685-692.